HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 87 filers reported holding HARVARD BIOSCIENCE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,315,879 | -16.7% | 1,933,966 | +6.4% | 0.00% | 0.0% |
| Q2 2023 | $9,979,121 | +36.1% | 1,817,629 | +4.2% | 0.00% | +50.0% |
| Q1 2023 | $7,329,650 | +151872.8% | 1,745,133 | +0.2% | 0.00% | +100.0% |
| Q4 2022 | $4,823 | -99.9% | 1,741,148 | -0.1% | 0.00% | -50.0% |
| Q3 2022 | $4,461,000 | -34.0% | 1,742,419 | -7.2% | 0.00% | 0.0% |
| Q2 2022 | $6,760,000 | -42.0% | 1,877,842 | -0.0% | 0.00% | -50.0% |
| Q1 2022 | $11,663,000 | -12.2% | 1,878,050 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $13,280,000 | -3.2% | 1,883,598 | -4.2% | 0.00% | 0.0% |
| Q3 2021 | $13,722,000 | -15.8% | 1,965,819 | +0.5% | 0.00% | -20.0% |
| Q2 2021 | $16,290,000 | +50.5% | 1,955,530 | -1.0% | 0.01% | +25.0% |
| Q1 2021 | $10,822,000 | +24.4% | 1,974,917 | -2.6% | 0.00% | +33.3% |
| Q4 2020 | $8,696,000 | +37.5% | 2,026,991 | -3.5% | 0.00% | 0.0% |
| Q3 2020 | $6,324,000 | -5.9% | 2,101,074 | -3.0% | 0.00% | 0.0% |
| Q2 2020 | $6,718,000 | +40.9% | 2,166,921 | +0.4% | 0.00% | +50.0% |
| Q1 2020 | $4,769,000 | -26.7% | 2,157,966 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $6,505,000 | -0.5% | 2,132,796 | +0.3% | 0.00% | -33.3% |
| Q3 2019 | $6,535,000 | +54.2% | 2,125,370 | +0.3% | 0.00% | +50.0% |
| Q2 2019 | $4,238,000 | -52.0% | 2,118,753 | +3.5% | 0.00% | -50.0% |
| Q1 2019 | $8,826,000 | +39.7% | 2,047,730 | +3.1% | 0.00% | +33.3% |
| Q4 2018 | $6,319,000 | -39.3% | 1,987,089 | +0.2% | 0.00% | -25.0% |
| Q3 2018 | $10,416,000 | +0.5% | 1,984,029 | +2.4% | 0.00% | 0.0% |
| Q2 2018 | $10,368,000 | +11.1% | 1,937,940 | +3.8% | 0.00% | 0.0% |
| Q1 2018 | $9,336,000 | +60.3% | 1,867,135 | +5.8% | 0.00% | +100.0% |
| Q4 2017 | $5,825,000 | -10.8% | 1,765,170 | +1.4% | 0.00% | -33.3% |
| Q3 2017 | $6,528,000 | +49.7% | 1,740,790 | +1.8% | 0.00% | +50.0% |
| Q2 2017 | $4,362,000 | +2.8% | 1,710,722 | +4.9% | 0.00% | 0.0% |
| Q1 2017 | $4,242,000 | -13.7% | 1,631,348 | +1.3% | 0.00% | 0.0% |
| Q4 2016 | $4,913,000 | +12.2% | 1,610,849 | +0.1% | 0.00% | 0.0% |
| Q3 2016 | $4,377,000 | -4.9% | 1,609,250 | -0.0% | 0.00% | -33.3% |
| Q2 2016 | $4,604,000 | -4.4% | 1,609,704 | +0.9% | 0.00% | 0.0% |
| Q1 2016 | $4,818,000 | -13.6% | 1,595,506 | -0.7% | 0.00% | 0.0% |
| Q4 2015 | $5,575,000 | -9.0% | 1,606,602 | -0.9% | 0.00% | -25.0% |
| Q3 2015 | $6,127,000 | -31.3% | 1,620,970 | +3.6% | 0.00% | -20.0% |
| Q2 2015 | $8,915,000 | +0.3% | 1,564,020 | +2.4% | 0.01% | -16.7% |
| Q1 2015 | $8,892,000 | +3.3% | 1,527,762 | +0.6% | 0.01% | 0.0% |
| Q4 2014 | $8,610,000 | +39.6% | 1,518,526 | +0.7% | 0.01% | +50.0% |
| Q3 2014 | $6,166,000 | -10.9% | 1,507,579 | -0.9% | 0.00% | -20.0% |
| Q2 2014 | $6,920,000 | -3.1% | 1,520,937 | +1.0% | 0.01% | 0.0% |
| Q1 2014 | $7,141,000 | +0.7% | 1,506,487 | -0.1% | 0.01% | -16.7% |
| Q4 2013 | $7,089,000 | -10.1% | 1,508,292 | +0.6% | 0.01% | -14.3% |
| Q3 2013 | $7,888,000 | +11.1% | 1,499,620 | -0.1% | 0.01% | 0.0% |
| Q2 2013 | $7,098,000 | – | 1,500,679 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |